The right way to diagnose infection

OrthoDx is revolutionising the orthopaedic landscape with Synvichor* – the world’s first genomic PCR test for rapid differentiation of joint pain.

*Synvichor is not approved by the TGA. For Research Use only. Not for use in diagnostic procedures.
Get in touch

Trusted by local and global clinical partners

Trusted by local and global clinical partners

Discover how

Every day, millions of people around the world present to their healthcare providers with undifferentiated joint pain.

With Synvichor, the guesswork has been taken out of diagnosis.

Watch and see how.

Redifiningdiagnosticelements Marquee
About Synvichor Synvichor Logo

Redefining diagnostic excellence

  • Developed by doctors, for doctors, Synvichor redefines diagnostic speed, accuracy and reliability.
  • Synvichor Native and Synvichor Prosthetic provide an unprecedented solution for every joint type, every time.
Discover how
Our technology

Delivering tomorrow’s technology, today

By harnessing the power of the immune system, our world-first gene expression technology sets a new medical standard globally.

Find out more
Our Technology Badge1

Contact us

Get in touch to find out how Synvichor can help you, your patients and your hospital.

Contact us

Be the first to know more as news breaks